SLNO Stock Analysis: Buy, Sell, or Hold?
SLNO - Soleno Therapeutics, Inc. Common Stock
$39.49
2.50 (6.76%)
▲
5d:
+23.95%
30d:
+3.57%
90d:
-14.71%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Distribution
SLNO is up 16.2% this week, but smart money is buying puts. Top strike: $30 2026-06-18 with 17,688 OI. Put ratio: 82% View Scanner →
Strength: 10.0/10
Get Alerted When SLNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SLNO shows positive signals but monitor for confirmation. Market pricing in 13.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: SLNO shows positive signals but monitor for confirmation. Market pricing in 13.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$116.27
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$72.19
45.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SLNO is currently trading at $39.49, which is considered extended relative to its 30-day fair value range of $32.54 to $39.45. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.0) compared to its historical average (9.1). Remarkably, the market is currently pricing in an annual earnings decline of 13.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SLNO is in a strong downtrend. The price is approaching resistance at $40.08. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: SLNO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $105.15 (+166.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SLNO is in a strong downtrend. The price is approaching resistance at $40.08. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: SLNO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $105.15 (+166.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$32.54 -
$39.45
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.8%)
- BULLISH: Trading 166.3% below Wall St target ($105.15)
Fair Price Analysis
30-Day Fair Range
$32.54 -
$39.45
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$29.43
Resistance Level
$40.08
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.02
Wall Street Target
$105.15
(+166.3%)
Profit Margin
11.0%
Valuation Discount vs History
-13.0% cheaper
PE vs Historical
6.0 vs 9.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.0%
(market-implied from PE analysis)
1-Year Target
$35.54
(-10%)
2-Year Target
$31.99
(-19%)
3-Year Target
$28.79
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6→9)
$43.52
(+10%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 68.7%)
$455.48
(+1053%)
Base:
(SPY PE: 6.0, Growth: 68.7%)
$133.28
(+238%)
Bear:
(PE: 5.1, Growth: 68.7%)
$113.29
(+187%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (8x PE), but valuation improves significantly next year (6x PE) as earnings recover.
Forward PE: 8.22 | Forward EPS (Implied): $3.86
Bull Case
$38.30
(+21%)
Analyst growth 15.0%, PE expands to 8.6
Base Case
$31.72
(0%)
Market implied 0.0%, PE stable at 8.2
Bear Case
$24.27
(-24%)
Severe decline -15.0%, PE contracts to 7.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.0 to 9.1
Stabilization Target:
$59.70
(+51.2%)
PE Expansion Potential:
+51.2%
Share & Embed Analysis
Last updated: April 02, 2026 8:20 PM ET
Data refreshes hourly during market hours. Next update: 9:20 PM
Data refreshes hourly during market hours. Next update: 9:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 58 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 61 BUY |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$290 | 53 HOLD |
Advanced SLNO Option Strategies
Professional options setups generated by AI based on today's SLNO price and gamma walls.
